0.00Open0.00Pre Close0 Volume0 Open Interest260.00Strike Price0.00Turnover0.00%IV-72.27%PremiumMay 16, 2025Expiry Date109.07Intrinsic Value100Multiplier16DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma1.38Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Natera Stock Discussion
Natera Announces Enrollment of First Patients in the HEROES Clinical Trial in Metastatic HER2+ Breast Cancer
How Natera's New Patent Could Reshape Cancer Detection Technology
Natera Scores Critical Medicare Coverage Win for Lung Cancer Test - What This Means for Patients and Investors
Major Clinical Guidelines Update: Natera's Cancer Test Shows 20x Better Risk Detection
-Billionaire investor Stanley Druckenmiller told Bloomberg on Wednesday that selling all his Nvidia stock this year was a “big mistake.”
-Nvidia was Druckenmiller's top holding a year ago, but he sold it after the stock tripled in 2023.
-The shares are up another 174% this year, and Druckenmiller has missed much of the continuing rally.
Stanley Druckenmiller is an American billionair...
No comment yet